Annual revenue fell from KRW 253.2 billion in 2022 to KRW 232.1 billion in 2023 (down 8.3% year on year) and KRW 218.2 billion in 2024 (down 6.0%), then rose to KRW 273.3 billion in 2025 (up 25.3%). Within 2022 to 2025, 2025 was the largest year for revenue and 2024 the smallest.
Operating profit dropped from KRW 29 billion in 2022 to KRW 17.4 billion in 2023 (down 40.1%) and KRW 9.97 billion in 2024 (down 42.6%), before edging up to KRW 10.9 billion in 2025 (up 9.3%).
The operating margin declined from 11.5% in 2022 to 7.5%, 4.6% and 4.0% in the following years, and in 2025 revenue grew 25.3% while operating profit grew only 9.3%, so top-line recovery did not translate directly into margin recovery.
Net income attributable to controlling shareholders went from KRW 19.6 billion in 2022 to KRW 18.2 billion in 2023 (down 6.9%), KRW 15.5 billion in 2024 (down 14.9%) and KRW 8.98 billion in 2025 (down 42.1%), declining for three consecutive years from 2023 to 2025.
Net income including non-controlling interests was KRW 8.96 billion in 2025, reported separately from the figure attributable to controlling shareholders. Operating cash flow ran at KRW 16.9 billion in 2022, -KRW 10.3 billion in 2023, KRW 36.2 billion in 2024 and -KRW 6.49 billion in 2025.
On a quarterly basis, operating profit moved from KRW 1.75 billion in Q3 2025 to KRW 2.27 billion in Q4 2025, KRW 5.12 billion in Q1 2026, KRW 5.35 billion in Q2 2026 and KRW 12.8 billion in Q3 2026, rising for four consecutive quarters from Q4 2025 to Q3 2026.
Revenue of KRW 74.8 billion in Q1 2026 (down 1.5% quarter on quarter) was the low point, and revenue then rose for two consecutive quarters to KRW 90.8 billion in Q3 2026 (up 13.3% quarter on quarter).
Net income attributable to controlling shareholders of KRW 5.73 billion in Q3 2026 rose 73.9% year on year, and the company reported a Q3 operating margin of 14.09% versus 3.07% a year earlier.
The company credited customer capex expansion, which raised equipment supply, together with better profitability for the quarterly improvement.